Home › Head and Neck Squamous Cell Carcinoma › NCT05451303
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
RecruitingObservational studyHealthy volunteers welcome
Detection of Oral and Throat Cancers Using Saliva Metatranscriptomic Analysis
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria * Signed Informed Consent obtained * 18 years and older * At a high risk of developing oral or throat cancer based on clinician's discretion Exclusion Criteria * Pregnancy * Use of fertility enhancing medications
About the study
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
What is being tested
- OralViome Cancer Testing System (device)
Sponsor: Viome · Participants: 475 · Started: May 27, 2022
Contact the study team
- Mory Mehrtash, MSc · Phone: 425-300-6933
- Momchilo Vuyisich, PhD · Phone: 425-300-6933
Official record on ClinicalTrials.gov — NCT05451303
Locations in the U.S.
| New York | NYMC, New York |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.